Five Biotech Events To Watch in 2010
Our senior biotech columnist offers his picks for the five biggest stock-moving events for 2010.
06:00AM 12/16/09
Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
Stocks will move if any of these unexpected events come true.
11:16AM 11/30/09
InterMune Shares Fall On Change In Hepatitis Study
InterMune shares fall as it stops high dose of experimental drug in hepatitis C study
11:58AM 11/17/09
Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
Mipomersen lowers cholesterol but not without liver side effects.
10:56AM 11/17/09
InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
Safety monitors force change to mid-stage study of ITMN-191
09:11AM 11/17/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
Vertex Jumps On Data For Twice-daily Telaprevir
Vertex Pharma hits 2-year high on data showing hepatitis C drug worked when given twice a day
02:25PM 11/02/09
Amylin Makes Obesity Drug Deal: BioBuzz
Japanese drugmaker Takeda licenses worldwide rights to Amylin weight-loss pipeline.
12:09PM 11/02/09
GTx CEO Blames FDA for Bone Drug Rejection: BioBuzz
Steiner claims FDA 'moved the goalposts" during acapodene review.
10:08AM 11/02/09
Dendreon Resubmits Provenge to FDA: BioBuzz
The approval decision for the prostate cancer vaccine will probably come in May 2010.
08:56AM 11/02/09
Vertex Hep C Drug Emerges From Weekend Looking Stronger: BioBuzz
Telaprevir is setting a high bar for its Hep C competitors.
07:26AM 11/02/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09
Vertex Hep C Drug Cures 80% at New Dose: Study
Data from a phase II study shows telaprevir as safe and effective when twice daily as it is taken thrice daily.
05:30PM 10/31/09
Idenix Down; Novartis Won't License Drug Candidate
Idenix Pharmaceuticals shares fall after Novartis opts out of hepatitis C drug program
12:46PM 10/30/09



Connect with TheStreet